Artificial Intelligence

Starkey and OrCam Partner to Provide Groundbreaking Assistive Technology to Hearing and Visually Impaired People

Partnership delivers a single solution to people who have both hearing and vision loss    Eden Prairie, Minnesota (October 28, 2020) – Two technology pioneers, each with a rich history of helping people live more independent, healthier lives, have teamed up to break new ground in assistive technology solutions. Hearing industry leader Starkey, and AI-driven artificial vision […]

Flywheel Launches Enterprise-Scale Medical Imaging Solution for Life Sciences

The solution streamlines and leverages imaging data assets and machine learning workflows, helping organizations increase R&D efficiency MINNEAPOLIS, June 4, 2020 /PRNewswire/ — Flywheel, a leading research data platform designed for the academic, clinical and life science communities, announced today its launch of Flywheel for Life Sciences. Flywheel for Life Sciences is an enterprise-scale research data management solution […]

Starkey’s Livio Edge AI Honored with MedTech Breakthrough Award

Eden Prairie, Minnesota (May 20, 2020) – In a packed crowd of 3,750 nominees, Starkey is proud to announce that Livio Edge AI has been selected as a winner of this year’s MedTech Breakthrough Awards. The awards honor excellence and recognize the creativity, hard work and success of health, fitness and medical technology companies, platforms, […]

PhysIQ’s Proprietary Personalized Analytics to be Used for COVID-19 Care with Newly Broadened FDA Labeling

PhysIQ announces FDA-sanctioned labeling to address the COVID-19 public health emergency with its proprietary Multivariate Change Index (MCI) Deployed within the pinpointIQ® continuous remote monitoring solution, physIQ’s MCI will be used to proactively monitor homebound patients with or vulnerable to COVID-19 The sophisticated, machine learning-based algorithm uses multiple continuous vital signs from wearable sensors to detect […]

PhysIQ and U.S. Veteran’s Affairs Publish Breakthrough Study Predicting Heart Failure Hospitalization up to 10 days in Advance using AI

PhysIQ and the U.S. VA publish results of a clinical trial that demonstrates how artificial intelligence (AI) applied to continuous wearable sensor data may predict hospitalizations. When coupled with the high sensor wear compliance rates, the 7-10-day early warning timeframe suggests this approach has great promise to reduce hospitalization and improve quality of life of […]

PhysIQ Expands Patent Portfolio for Artificial Intelligence Analytics in Wearables

PhysIQ receives patent for game-changing deep net approach to estimating functional capacity daily from continuous wearable sensor data. PhysIQ’s adds yet another patent to its extensive portfolio on personalized physiology analytics powered by the similarity-based modeling machine learning approach. CHICAGO, IL – PhysIQ continues to receive recognition for the novelty and value of its technology with the […]

StemoniX and Atomwise Create Joint Venture Aligning microOrgan® and AI Technologies for “Next Generation” Drug Discovery

Companies to focus on small molecule discovery for Rett syndrome MAPLE GROVE, Minn. and SAN FRANCISCO, Dec. 3, 2019 /PRNewswire/ — StemoniX, Inc. and Atomwise Inc. today announced a joint venture that combines StemoniX’s human microOrgan® platform with Atomwise’s AI technology to enable the rapid discovery and development of novel small molecule therapies. The joint venture will initially target Rett syndrome, a rare […]

Corvia Medical and physIQ Partner in Global Phase 3 Heart Failure Clinical Trial to Leverage Novel Digital Endpoints

The 100+ site global Phase 3 clinical trial is the first-of-its-kind to leverage continuous multivariate wearable sensor data and Artificial Intelligence-based analytics The landmark trial endpoint approach aligns with commentary at a recent FDA Public Workshop on biomarkers for heart failure clinical trials To date, hundreds of thousands of hours of continuous multivariate sensor data […]

PhysIQ Inc. Receives FDA Clearance of Continuous Ambulatory Respiration Rate Algorithm Enabling Artificial Intelligence-based Analytics for Biopharma Companies and Payers

FDA 510(k) cleared Respiration Rate analytic adds to physIQ’s growing portfolio of FDA 510(k) algorithms Clearance allows physIQ to power its higher-level AI analytics with validated vital sign inputs PhysIQ’s cloud-based analytics provide flexibility to biopharma companies and payers looking for consistent output while deploying a variety of devices across different patient populations CHICAGO – PhysIQ, […]

“AI” And “IP”: Two Small Letters with Big Impact

By Lauren J.F. Barta and Timothy E. Grimsrud Artificial Intelligence is already used in healthcare in a multitude of ways, including robotic-assisted surgery, virtual nursing assistants, diagnostics, drug discovery, hospital workflow, consumer integrated health, and personalized medicine, and its use is only expected to grow.[1] AI technologies are able to sense, comprehend, act, and learn—this […]

Keep your finger on the pulse of Medical Alley from anywhere with the ALLEY NEWSLETTER